Craif
Tokyo, JP · Founded 2018 · Japan corporation · 3 known investors
Craif develops biomarker analysis and AI-driven diagnostic solutions to enable early disease detection and personalized treatment through non-invasive testing of body fluids.
AI & Machine LearningBiotechHealthtechMedical Devices
Founders & leadership
RO
Ryuichi OnoseExecutive Officer, Director
YI
Yuki IchikawaDirector
MY
Mika YuiDirector
Investors · 3
Reported raises · per SEC filings
Form D private placements▶$11.3MraisedNov 2021 · 4 investors · Other Health CareRule 506(b)
▶$11.3MraisedNov 2021 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ryuichi OnoseExecutive Officer, Director
- Yuki IchikawaDirector
- Mika YuiDirector
- Offering amount
- $26.9M
- Amount sold
- $11.3M
- First sale
- Oct 2021
- Incorporated
- Corporation, Japan, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.